Table 7.

Summary of results with chemotherapy and cetuximab for the treatment of advanced cutaneous squamous cell carcinoma (CSCC).

	Overall Response Rate	Duration of Response	Progression-Free Survival
Chemotherapy [63]	44%	Not available	5.5 months
Cetuximab [67,68]	28–48.5%	5 months	4.1–9 months